Vetoquinol SA

VETO

FR0004186856

Pharmaceuticals

Real-time Euronext Paris Other stock markets 11:08:38 2024-05-17 am EDT			5-day change	1st Jan Change
101.4 ^EUR	+2.11%		+3.36%	-0.98%

Apr. 30	Vetoquinol: down after sales update	CF
Apr. 29	Vetoquinol SA Reports Sales Results for the First Quarter of Fiscal 2024	CI

Vetoquinol SA Proposes Dividend

April 06, 2021

Vetoquinol SA board will propose a dividend of €0.50 per share to the May 27th, 2021 shareholders' meeting.

Latest news about Vetoquinol SA

Vetoquinol: down after sales update	Apr. 30	CF
Vetoquinol SA Reports Sales Results for the First Quarter of Fiscal 2024	Apr. 29	CI
Vetoquinol SA Proposes Dividend	Mar. 20	CI
Vetoquinol SA Reports Earnings Results for the Full Year Ended December 31, 2023	Mar. 19	CI
VETOQUINOL : Stifel downgrades its recommendation	Jan. 25	CF
Vetoquinol: 2% drop in annual sales	Jan. 25	CF
Vetoquinol SA Announces Sales Results for the Full Year 2023	Jan. 24	CI
Valneva: share price in demand on eve of earnings release	Nov. 08	CF
Vetoquinol: down slightly after quarterly sales figures	23-10-27	CF
Vetoquinol Sa Announces Sales Results for the Third-Quarter and Nine Months of 2023	23-10-26	CI
Vetoquinol: net income up 51% in 1st half	23-09-08	CF
Vetoquinol SA Reports Earnings Results for the Half Year Ended June 30, 2023	23-09-07	CI
CAC40: towards a green start to the session	23-05-26	CF
Vetoquinol: new Chairman of the Board in early July	23-05-26	CF
Vetoquinol Chairman to Step Down; CEO Named Successor	23-05-26	MT
Vetoquinol SA Approves Dividend, Payable on 6 June 2023	23-05-25	CI
Vetoquinol SA Announces Executive Changes	23-05-25	CI
Vetoquinol: upbeat after sales figures	23-04-20	CF
Vetoquinol SA Announces Sales Results for the First Quarter of Financial Year 2023	23-04-19	CI
Global markets live: Shell, UBS, Nvidia, Coinbase, Block...	23-03-23
Vetoquinol: net income down 24% by 2022	23-03-23	CF
Vetoquinol SA Reports Earnings Results for the Full Year Ended December 31, 2022	23-03-23	CI
Vetoquinol SA Proposes Dividend	23-03-23	CI
VETOQUINOL : Stifel lowers its target price	23-02-07	CF
Vetoquinol: sales growth of nearly 4% in 2022	23-01-19	CF

Vetoquinol SA specializes in the research, development, production and marketing of veterinary drugs and products for pets (67.7% of net sales; dogs, cats, etc.) and livestock (32.3%; cattle, pigs, poultry, etc.). The group's activity is organized around 4 product families: - antibiotics; - anti-inflammatories; - cardiology and nephrology treatments; - other: anti-parasitics, vaccines, and nutritional products. At the end of 2022, the group had 5 production sites throughout the world. Net sales are distributed geographically as follows: Europe (46.7%), the Americas (36%) and Asia/Pacific (17.3%).

Sector

Pharmaceuticals

Calendar

2024-05-27 - Annual General Meeting

More about the company

Income Statement Evolution

More financial data

Ratings for Vetoquinol SA

Trading Rating

Investor Rating

ESG Refinitiv

More Ratings

Analysts' Consensus

Sell

Buy

Mean consensus

HOLD

Number of Analysts

Last Close Price

99.3 EUR

Average target price

105.7 EUR

Spread / Average Target

+6.41%

Consensus

EPS Revisions

Estimates Revisions

Quarterly revenue - Rate of surprise

Company calendar

Sector Veterinary Drugs

	1st Jan change	Capi.
VETOQUINOL SA	-0.98%	1.28B
ZOETIS INC.	-11.73%	79.26B
ELANCO ANIMAL HEALTH INCORPORATED	+16.68%	8.39B
BLUESTAR ADISSEO COMPANY	+28.00%	3.74B
VIRBAC	-1.53%	3.27B
VIMIAN GROUP AB	+17.23%	1.69B
JINYU BIO-TECHNOLOGY CO., LTD.	-3.25%	1.56B
CHINA ANIMAL HUSBANDRY INDUSTRY CO., LTD.	-18.63%	1.29B
WUHAN KEQIAN BIOLOGY CO.,LTD	-6.77%	1.14B
TIANJIN RINGPU BIO-TECHNOLOGY CO.,LTD.	+0.79%	1.06B

Veterinary Drugs

Vetoquinol SA

Equities

VETO

FR0004186856

Pharmaceuticals

Vetoquinol SA Proposes Dividend

Latest news about Vetoquinol SA

Chart Vetoquinol SA

Company Profile

Income Statement Evolution

Ratings for Vetoquinol SA

Analysts' Consensus

EPS Revisions

Quarterly revenue - Rate of surprise

Sector Veterinary Drugs